Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
Abstract Objective: Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox‐Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC).…